Zacks Investment Research
03 Sept 2026, 14:55 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Analysis by Kasper Rasmussen · Founder & analyst
What the story claims
3 claims · each scored for market impact
The mean analyst price target for Nuvation Bio Inc. (NUVB) is $13.30, representing a potential upside of 91.9% from its current price of $6.93. — A significant gap between current price and consensus targets typically attracts bullish speculative interest.
+0.60Analysts are collectively revising their earnings estimates for Nuvation Bio Inc. upward. — Positive earnings estimate revisions are generally a leading indicator of stock price appreciation.
+0.40Nuvation Bio Inc. shares have gained 8.8% over the past four weeks. — Short-term positive momentum confirms recent buyer interest but is a lagging indicator.
+0.10Which stocks this story touches
Continue reading
6 related stories
Top 1 mover · tap to explore
The stock shows strong upside potential based on analyst price targets and positive earnings estimate revisions.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Seeking Alpha
2h ago
